Breaking News
3 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Cipla launches Ciposcillo, a next-generation oscillometer targeting early diagnosis of COPD and asthma in the respiratory diagnostics segment.
Pharma Now Editorial Team

Medicus Pharma's 200µg D-MNA cohort hits 55% complete response at Day 57, advancing toward FDA End-of-Phase 2 discussions for nodular BCC.
Pharma Now Editorial Team

Madrigal secures global rights to Arrowhead's GalNAc-siRNA ARO-PNPLA3 as Rezdiffra Q1 sales hit $311.3M, up 127% year-over-year.
Pharma Now Editorial Team

Tonix secures GPO coverage for TONMYA sublingual tablets, reaching 35 million U.S. commercial lives as Medicare talks continue.
Pharma Now Editorial Team
